Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 372 participants.

Also called NCT01826552

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 372 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01826552
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01826552. Randomized; no masking; primary purpose treatment. Start 2013-09 (registry gives no type); primary completion 2015-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent
Acronym
ORIENT
Condition
Coronary Heart Disease
Condition
Stable Angina
Condition
Unstable Angina
Condition
ST-segment Elevation Myocardial Infarction
Condition
Non-ST-segment Elevation Myocardial Infarction
Intervention (Device)
Osiro Hybrid Drug-Eluting Stent
Intervention (Device)
Resolute Integrity
Lead sponsor
Seoul National University Bundang Hospital (class: other)
Collaborator
Jeju National University Hospital (class: other)
Collaborator
Chungbuk National University Hospital (class: other)
Collaborator
SMG-SNU Boramae Medical Center (class: other)
Collaborator
Korea University (class: other)
Collaborator
Inje University (class: other)
Collaborator
Kyung Hee University Hospital at Gangdong (class: other)
Collaborator
Inha University Hospital (class: other)

Record details

Record id
cardio:ct-nct01826552
Content hash
b00293666ff63b4d6002bb465febc7aa35ecb281942897392daed6cfdbad3f15